P2-08 LEGEND: A PHASE 1/2 STUDY OF EG-70 (DETALIMOGENE VORAPLASMID), A NOVEL, NON-VIRAL INTRAVESICAL GENE THERAPY FOR PATIENTS WITH BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER WITH CARCINOMA IN SITU (CIS)
Journal of Urology（2024）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要